NHS Logo
  • Home
  • About Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter
  • Contact Us

Treatment Stories

Treatment Flexible hepatitis C treatments could pave the way for elimination

Treatment Flexible hepatitis C treatments could pave the way for elimination

Published on 8th May 2025
PreventionTreatment New research sheds light on ongoing bowel cancer surveillance needs

PreventionTreatment New research sheds light on ongoing bowel cancer surveillance needs

Published on 30th April 2025
Treatment New Lancet Commission calls for rethink on coronary artery disease

Treatment New Lancet Commission calls for rethink on coronary artery disease

Published on 1st April 2025
Treatment RIO Study: New antibody therapies could offer alternative to current treatments

Treatment RIO Study: New antibody therapies could offer alternative to current treatments

Published on 11th March 2025
Treatment Innovative inhalable gene therapy trialled to treat cystic fibrosis

Treatment Innovative inhalable gene therapy trialled to treat cystic fibrosis

Published on 20th February 2025
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Treatment Flexible hepatitis C treatments could pave the way for elimination
  • Training NIHR Imperial BRC pre-application support funds
  • Prevention Progesterone-only contraceptive pill linked to increased asthma risk in some women
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre